These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 7808038)

  • 21. Valproic acid: brain and plasma levels of the drug and its metabolites, anticonvulsant effects and gamma-aminobutyric acid (GABA) metabolism in the mouse.
    Nau H; Löscher W
    J Pharmacol Exp Ther; 1982 Mar; 220(3):654-9. PubMed ID: 6801254
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiple effects of pentyl-4-yn-VPA enantiomers: from toxicity to short-term memory enhancement.
    Gotfryd K; Owczarek S; Hoffmann K; Klementiev B; Nau H; Berezin V; Bock E; Walmod PS
    Neuropharmacology; 2007 Mar; 52(3):764-78. PubMed ID: 17095022
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alpha-fluoro-2,2,3,3-tetramethylcyclopropanecarboxamide, a novel potent anticonvulsant derivative of a cyclic analogue of valproic acid.
    Pessah N; Bialer M; Wlodarczyk B; Finnell RH; Yagen B
    J Med Chem; 2009 Apr; 52(8):2233-42. PubMed ID: 19296679
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anticonvulsant activity, neural tube defect induction, mutagenicity and pharmacokinetics of a new potent antiepileptic drug, N-methoxy-2,2,3,3-tetramethylcyclopropane carboxamide.
    Sobol E; Yagen B; Lamb JG; White HS; Wlodarczyk BJ; Finnell RH; Bialer M
    Epilepsy Res; 2007 Jan; 73(1):75-84. PubMed ID: 16997532
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hydroxamic acid and fluorinated derivatives of valproic acid: anticonvulsant activity, neurotoxicity and teratogenicity.
    Gravemann U; Volland J; Nau H
    Neurotoxicol Teratol; 2008; 30(5):390-4. PubMed ID: 18455366
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Teratogenicity of valproate conjugates with anticonvulsant activity in mice.
    Spiegelstein O; Chatterjie N; Alexander G; Finnell RH
    Epilepsy Res; 2003 Dec; 57(2-3):145-52. PubMed ID: 15013055
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of nimodipine on the cognitive dysfunction induced by phenytoin and valproate in rats.
    Balakrishnan S; Pandhi P
    Methods Find Exp Clin Pharmacol; 1997 Dec; 19(10):693-7. PubMed ID: 9542719
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tetramethylcyclopropyl analogue of the leading antiepileptic drug, valproic acid: evaluation of the teratogenic effects of its amide derivatives in NMRI mice.
    Okada A; Onishi Y; Yagen B; Shimshoni JA; Kaufmann D; Bialer M; Fujiwara M
    Birth Defects Res A Clin Mol Teratol; 2008 Sep; 82(9):610-21. PubMed ID: 18671279
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Disposition of valpromide, valproic acid, and valnoctamide in the brain, liver, plasma, and urine of rats.
    Blotnik S; Bergman F; Bialer M
    Drug Metab Dispos; 1996 May; 24(5):560-4. PubMed ID: 8723737
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aspirin modulates the anticonvulsant effect of diazepam and sodium valproate in pentylenetetrazole and maximal electroshock induced seizures in mice.
    Srivastava AK; Gupta YK
    Indian J Physiol Pharmacol; 2001 Oct; 45(4):475-80. PubMed ID: 11883156
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anticonvulsive properties of calcitonin in rats.
    Sobaniec W; Kułak W
    Eur Neuropsychopharmacol; 1992 Dec; 2(4):443-6. PubMed ID: 1490095
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Levetiracetam, phenytoin, and valproate act differently on rat bone mass, structure, and metabolism.
    Nissen-Meyer LS; Svalheim S; Taubøll E; Reppe S; Lekva T; Solberg LB; Melhus G; Reinholt FP; Gjerstad L; Jemtland R
    Epilepsia; 2007 Oct; 48(10):1850-60. PubMed ID: 17634065
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of levetiracetam and valproate on reproductive endocrine function studied in human ovarian follicular cells.
    Taubøll E; Gregoraszczuk EL; Wojtowicz AK; Milewicz T
    Epilepsia; 2009 Aug; 50(8):1868-74. PubMed ID: 19490055
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemical and immunochemical comparison of protein adduct formation of four carboxylate drugs in rat liver and plasma.
    Bailey MJ; Dickinson RG
    Chem Res Toxicol; 1996; 9(3):659-66. PubMed ID: 8728513
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Valproate reduced synaptic activity increase induced by 4-aminopyridine at the hippocampal CA3-CA1 synapse.
    Martín ED; Pozo MA
    Epilepsia; 2004 May; 45(5):436-40. PubMed ID: 15101824
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacodynamic interaction between phenytoin and sodium valproate changes seizure thresholds and pattern.
    Della Paschoa OE; Kruk MR; Hamstra R; Voskuyl RA; Danhof M
    Br J Pharmacol; 1998 Nov; 125(5):997-1004. PubMed ID: 9846637
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum and liver tissue biotinidase enzyme activity in rats which were administrated to valproic acid.
    Korkmazer N; Vurucu S; Demirkaya E; Unay B; Kul M; Akin R; Gokcay E
    Brain Dev; 2006 Sep; 28(8):515-20. PubMed ID: 16682156
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Valproate- and aminophylline-induced 'wet dog shakes'--a function of dose and time.
    Jose PE; Kullu P; David J; Kulkarni C
    Pol J Pharmacol; 1999; 51(4):357-61. PubMed ID: 10540968
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Lithium valproate: its neuropharmacological spectrum and effect on transmitter amino acid content of the brain of rats].
    Kharlamov AN; Shumkova OV; Blinkova NF; Tolmacheva NS; Raevskiĭ KS
    Farmakol Toksikol; 1984; 47(5):11-5. PubMed ID: 6149951
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Additive anticonvulsant effect of flunarizine and sodium valproate on electroshock and chemoshock induced seizures in mice.
    Joseph S; David J; Joseph T
    Indian J Physiol Pharmacol; 1998 Jul; 42(3):383-8. PubMed ID: 9741653
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.